{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:19:04Z","timestamp":1784114344018,"version":"3.55.0"},"reference-count":168,"publisher":"Elsevier","isbn-type":[{"value":"9780323988490","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.acc.2021.07.006","type":"book-chapter","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:24:19Z","timestamp":1654043059000},"page":"37-71","source":"Crossref","is-referenced-by-count":54,"title":["Diabetes and cognitive decline"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2021.07.006_bb0010","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/bs.acc.2021.07.006_bb0015","doi-asserted-by":"crossref","first-page":"108078","DOI":"10.1016\/j.diabres.2020.108078","article-title":"Diabetes and global ageing among 65-99-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"162","author":"Sinclair","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the U.S. in 2017","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"issue":"18","key":"10.1016\/bs.acc.2021.07.006_bb0025","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0030","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2337\/dc17-0954","article-title":"Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany","volume":"40","author":"Jacobs","year":"2017","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0035","first-page":"999","article-title":"Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease","volume":"3","author":"Bellia","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/bs.acc.2021.07.006_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diabres.2019.04.031","article-title":"Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers","volume":"152","author":"Meloni","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0045","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1007\/s00125-005-0023-4","article-title":"Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies","volume":"48","author":"Cukierman","year":"2005","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/bs.acc.2021.07.006_bb0050","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneurol.2012.1117","article-title":"Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia","volume":"69","author":"Yaffe","year":"2012","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0055","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00125-009-1323-x","article-title":"Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study","volume":"52","author":"Xu","year":"2009","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jdi.12087","article-title":"Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies","volume":"4","author":"Gudala","year":"2013","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/bs.acc.2021.07.006_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer's disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(14)70249-2","article-title":"Cognitive function in patients with diabetes mellitus: guidance for daily care","volume":"14","author":"Koekkoek","year":"2015","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/bs.acc.2021.07.006_bb0075","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1212\/WNL.0000000000000269","article-title":"Association of type 2 diabetes with brain atrophy and cognitive impairment","volume":"82","author":"Roberts","year":"2014","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0080","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.2337\/dc13-0143","article-title":"Brain atrophy in type 2 diabetes: regional distribution and influence on cognition","volume":"36","author":"Moran","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.diabet.2017.06.004","article-title":"Brain atrophy in ageing: estimating effects of blood glucose levels vs. other type 2 diabetes effects","volume":"44","author":"Walsh","year":"2018","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-019-04977-9","article-title":"Cognitive dysfunction in diabetes: how to implement emerging guidelines","volume":"63","author":"Biessels","year":"2020","journal-title":"Diabetologia"},{"issue":"Suppl. 1","key":"10.1016\/bs.acc.2021.07.006_bb0095","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.2337\/dc20-S012","article-title":"Older adults: standards of medical care in diabetes","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0100","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of diabetes in older adults: an endocrine society* clinical practice guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jdi.12599","article-title":"Committee report: glycemic targets for elderly patients with diabetes: Japan Diabetes Society (JDS)\/Japan Geriatrics Society (JGS) Joint Committee on Improving Care for Elderly Patients with Diabetes","volume":"8","author":"Japan Diabetes Society\/Japan Geriatrics Society","year":"2017","journal-title":"J. Diabetes Investig."},{"issue":"9","key":"10.1016\/bs.acc.2021.07.006_bb0110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/dme.12467","article-title":"Diabetes and dementia in older people: a Best Clinical Practice Statement by a multidisciplinary National Expert Working Group","volume":"31","author":"Sinclair","year":"2014","journal-title":"Diabet. Med."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.diabres.2014.03.005","article-title":"New IDF guideline for managing type 2 diabetes in older people","volume":"103","author":"Dunning","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-8587(20)30118-2","article-title":"Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities","volume":"8","author":"Srikanth","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"10.1016\/bs.acc.2021.07.006_bb0125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.0b013e31826846de","article-title":"Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH Study","volume":"79","author":"Cherbuin","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000175","article-title":"Higher fasting plasma glucose is associated with striatal and hippocampal shape differences: the 2sweet project","volume":"4","author":"Zhang","year":"2016","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"10","key":"10.1016\/bs.acc.2021.07.006_bb0135","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1212\/01.WNL.0000161871.83614.BB","article-title":"Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects","volume":"64","author":"Enzinger","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s10548-017-0544-4","article-title":"Higher fasting plasma glucose is associated with increased cortical thinning over 12 years: the path through life study","volume":"30","author":"Shaw","year":"2017","journal-title":"Brain Topogr."},{"issue":"9","key":"10.1016\/bs.acc.2021.07.006_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073697","article-title":"High \"normal\" blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the path through life study","volume":"8","author":"Mortby","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/13803390903540323","article-title":"Effect of age and glucoregulation on cognitive performance","volume":"32","author":"Messier","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0160","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2337\/db09-0568","article-title":"A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study","volume":"59","author":"Euser","year":"2010","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12902-018-0318-3","article-title":"Pre-diabetes and diabetes are independently associated with adverse cognitive test results: a cross-sectional, population-based study","volume":"18","author":"Dybjer","year":"2018","journal-title":"BMC Endocr. Disord."},{"issue":"13","key":"10.1016\/bs.acc.2021.07.006_bb0170","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1212\/WNL.0000000000005214","article-title":"Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation","volume":"90","author":"Ekblad","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2014.12.014","article-title":"Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study","volume":"16","author":"Abbatecola","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0180","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/dc14-0599","article-title":"Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia","volume":"38","author":"Thorpe","year":"2015","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/bs.acc.2021.07.006_bb0185","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s00125-009-1484-7","article-title":"Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the action in diabetes and vascular disease: preterax and diamicron modified release controlled evaluation (ADVANCE) trial","volume":"52","author":"de Galan","year":"2009","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.acc.2021.07.006_bb0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/epirev\/mxs012","article-title":"Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship","volume":"35","author":"Vagelatos","year":"2013","journal-title":"Epidemiol. Rev."},{"issue":"10","key":"10.1016\/bs.acc.2021.07.006_bb0200","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00702-010-0456-x","article-title":"Cerebrospinal fluid insulin during non-neurological surgery","volume":"117","author":"Bromander","year":"2010","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0205","first-page":"C125","article-title":"Insulin transport into the brain","volume":"315","author":"Gray","year":"2018","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00702-004-0163-6","article-title":"Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt)","volume":"112","author":"Kim","year":"2005","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0215","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1471-4159.2005.03269.x","article-title":"Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner","volume":"94","author":"van der Heide","year":"2005","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0220","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","article-title":"Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo","volume":"58","author":"Chiu","year":"2008","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0225","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","article-title":"Central nervous pathways of insulin action in the control of metabolism and food intake","volume":"8","author":"Kullmann","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/bs.acc.2021.07.006_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-10-37","article-title":"Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators","volume":"10","author":"Suh","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"15","key":"10.1016\/bs.acc.2021.07.006_bb0235","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.3390\/ijms20153702","article-title":"The protective effect of insulin on rat cortical neurons in oxidative stress and its dependence on the modulation of Akt, GSK-3beta, ERK1\/2, and AMPK activities","volume":"20","author":"Zakharova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02294","article-title":"Insulin attenuates apoptosis in neuronal cells by an integrin-linked kinase-dependent mechanism","volume":"5","author":"Tan","year":"2019","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/bs.acc.2021.07.006_bb0245","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0250","doi-asserted-by":"crossref","first-page":"E1331","DOI":"10.1152\/ajpendo.00084.2013","article-title":"Antecedent glycemic control reduces severe hypoglycemia-induced neuronal damage in diabetic rats","volume":"304","author":"Reno","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.acc.2021.07.006_bb0260","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1749-6632.1999.tb07839.x","article-title":"A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease","volume":"893","author":"Fr\u00f6lich","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0265","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0270","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/db07-0171","article-title":"Alzheimer-like changes in rat models of spontaneous diabetes","volume":"56","author":"Li","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0275","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","volume":"11","author":"Willette","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032792","article-title":"Mechanisms underlying insulin deficiency-induced acceleration of \u03b2-amyloidosis in a mouse model of Alzheimer's disease","volume":"7","author":"Devi","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0285","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.2337\/db14-0375","article-title":"Insulin reverses the high-fat diet-induced increase in brain A\u03b2 and improves memory in an animal model of Alzheimer disease","volume":"63","author":"Vandal","year":"2014","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0290","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.4161\/auto.21861","article-title":"Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions","volume":"8","author":"Son","year":"2012","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0295","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03346691","article-title":"Impaired amyloid \u03b2-degrading enzymes in brain of streptozotocin-induced diabetic rats","volume":"34","author":"Liu","year":"2011","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0305","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/s41598-017-02660-w","article-title":"Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue","volume":"7","author":"Ca\u00ebr","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0310","first-page":"382","article-title":"A risk score derived from the analysis of a cluster of 27 serum inflammatory cytokines to predict long term outcome in patients with acute myocardial infarction: a pilot study","volume":"45","author":"Novo","year":"2015","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0315","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1534734614544959","article-title":"High matrix metalloproteinase levels are associated with dermal graft failure in diabetic foot ulcers","volume":"13","author":"Izzo","year":"2014","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/bs.acc.2021.07.006_bb0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fnagi.2020.00201","article-title":"Strawberry leaf extract treatment alleviates cognitive impairment by activating Nrf2\/HO-1 signaling in rats with streptozotocin-induced diabetes","volume":"12","author":"Zhang","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228750","article-title":"The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation","volume":"15","author":"Ide","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21051746","article-title":"Liraglutide protects against brain amyloid-\u03b2(1-42) accumulation in female mice with early Alzheimer's disease-like pathology by partially rescuing oxidative\/nitrosative stress and inflammation","volume":"21","author":"Duarte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.acc.2021.07.006_bb0335","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2017.10.012","article-title":"Neuroprotective effects of a triple GLP-1\/GIP\/glucagon receptor agonist in the APP\/PS1 transgenic mouse model of Alzheimer's disease","volume":"1678","author":"Tai","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/bs.acc.2021.07.006_bb0340","doi-asserted-by":"crossref","first-page":"116566","DOI":"10.1016\/j.lfs.2019.116566","article-title":"The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis","volume":"231","author":"Yan","year":"2019","journal-title":"Life Sci."},{"issue":"Pt. A","key":"10.1016\/bs.acc.2021.07.006_bb0345","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.physbeh.2015.09.007","article-title":"Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia","volume":"152","author":"Jain","year":"2015","journal-title":"Physiol. Behav."},{"issue":"22","key":"10.1016\/bs.acc.2021.07.006_bb0350","doi-asserted-by":"crossref","first-page":"15590","DOI":"10.1074\/jbc.M112.440784","article-title":"Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress","volume":"288","author":"Zhao","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0355","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","article-title":"Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective","volume":"19","author":"Biessels","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0360","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41598-018-37215-0","article-title":"Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation","volume":"9","author":"Hsieh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2021.07.006_bb0365","doi-asserted-by":"crossref","first-page":"36746","DOI":"10.1038\/srep36746","article-title":"High glucose upregulates BACE1-mediated A\u03b2 production through ROS-dependent HIF-1\u03b1 and LXR\u03b1\/ABCA1-regulated lipid raft reorganization in SK-N-MC cells","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2021.07.006_bb0370","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1742-2094-9-182","article-title":"Recurrent\/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment in diabetic rats","volume":"9","author":"Won","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0375","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.25570","article-title":"Amylin as a potential link between type 2 diabetes and alzheimer disease","volume":"86","author":"Martinez-Valbuena","year":"2019","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0380","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-160047","article-title":"Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1\u03b2 synthesis in brains of Alzheimer's disease patients with type-2 diabetes and in diabetic HIP rats","volume":"53","author":"Verma","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0385","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/jgs.15886","article-title":"Brain aging in midlife: the beaver dam offspring study","volume":"67","author":"Schubert","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"issue":"10","key":"10.1016\/bs.acc.2021.07.006_bb0390","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ggi.12602","article-title":"Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus","volume":"16","author":"Bozluolcay","year":"2016","journal-title":"Geriatr Gerontol Int"},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0395","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/gerona\/gly217","article-title":"The cross-sectional and longitudinal associations between IL-6, IL-10, and TNF\u03b1 and cognitive outcomes in the mayo clinic study of aging","volume":"74","author":"Wennberg","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"14","key":"10.1016\/bs.acc.2021.07.006_bb0400","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1212\/WNL.0b013e3182315a56","article-title":"Advanced glycation end product level, diabetes, and accelerated cognitive aging","volume":"77","author":"Yaffe","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0405","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamaneurol.2016.0150","article-title":"Association between genetic traits for immune-mediated diseases and Alzheimer disease","volume":"73","author":"Yokoyama","year":"2016","journal-title":"JAMA Neurol."},{"issue":"Suppl. 1","key":"10.1016\/bs.acc.2021.07.006_bb0410","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2021.07.006_bb0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clinbiochem.2018.02.017","article-title":"Clinical usefulness of Glycated Albumin in the diagnosis of diabetes: results from an Italian study","volume":"54","author":"Bellia","year":"2018","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0420","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1515\/cclm-2017-0179","article-title":"Definition of the upper reference limit of glycated albumin in blood donors from Italy","volume":"56","author":"Bellia","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/bs.acc.2021.07.006_bb0425","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365513.2019.1613673","article-title":"Glycated albumin as a glycaemic marker in patients with advanced chronic kidney disease and anaemia: a preliminary report","volume":"79","author":"Bellia","year":"2019","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0430","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1373\/clinchem.2016.258319","article-title":"High glycated albumin and mortality in persons with diabetes mellitus on hemodialysis","volume":"63","author":"Chen","year":"2017","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0435","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/ndt\/gfy014","article-title":"Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study","volume":"33","author":"Hoshino","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ageing\/afy178","article-title":"Relationship between HbA1c and all-cause mortality in older patients with insulin-treated type 2 diabetes: results of a large UK Cohort Study","volume":"48","author":"Anyanwagu","year":"2019","journal-title":"Age Ageing"},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0445","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1210\/jc.2018-02536","article-title":"Glycated hemoglobin and all-cause and cause-specific mortality among adults with and without diabetes","volume":"104","author":"Li","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0450","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/1479164116653356","article-title":"Fasting glucose levels, incident diabetes, subclinical atherosclerosis and cardiovascular events in apparently healthy adults: A 12-year longitudinal study","volume":"13","author":"Sitnik","year":"2016","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"10","key":"10.1016\/bs.acc.2021.07.006_bb0455","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/dc09-2328","article-title":"Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range","volume":"33","author":"Ning","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0460","article-title":"Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis","volume":"7","author":"Cavero-Redondo","year":"2017","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0465","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000330020","article-title":"Vascular risk factors and dementia: 40-year follow-up of a population-based cohort","volume":"31","author":"R\u00f6nnemaa","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0470","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neurobiolaging.2013.09.033","article-title":"Impaired glycemia increases disease progression in mild cognitive impairment","volume":"35","author":"Morris","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.acc.2021.07.006_bb0475","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12883-016-0646-8","article-title":"Predicting dementia in primary care patients with a cardiovascular health metric: a prospective population-based study","volume":"16","author":"Hessler","year":"2016","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/bs.acc.2021.07.006_bb0480","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003112","article-title":"Late-life risk factors for all-cause dementia and differential dementia diagnoses in women: a prospective cohort study","volume":"95","author":"Neergaard","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0485","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1210\/jc.2015-1367","article-title":"Dysglycemia and cognitive dysfunction and ill health in people with High CV risk: results from the ONTARGET\/TRANSCEND studies","volume":"100","author":"Cukierman-Yaffe","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0490","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/db06-0879","article-title":"The effect of borderline diabetes on the risk of dementia and Alzheimer's disease","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0495","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2337\/db16-1444","article-title":"Metabolic syndrome, insulin resistance, and cognitive dysfunction: does your metabolic profile affect your brain?","volume":"66","author":"Neergaard","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0500","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-170153","article-title":"Midlife metabolic profile and the risk of late-life cognitive decline","volume":"59","author":"Tortelli","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0505","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1532-5415.2012.04081.x","article-title":"Development of vascular risk factors over 15 years in relation to cognition: the Hoorn Study","volume":"60","author":"Reijmer","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"issue":"9","key":"10.1016\/bs.acc.2021.07.006_bb0510","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/dc16-2238","article-title":"Visit-to-visit variations in fasting plasma glucose and HbA(1c) associated with an increased risk of Alzheimer disease: taiwan diabetes study","volume":"40","author":"Li","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2021.07.006_bb0515","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2458-8-54","article-title":"An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study","volume":"8","author":"Gao","year":"2008","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/bs.acc.2021.07.006_bb0520","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/M14-0737","article-title":"Diabetes in midlife and cognitive change over 20 years: a cohort study","volume":"161","author":"Rawlings","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/bs.acc.2021.07.006_bb0525","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2017.02.014","article-title":"Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76","volume":"54","author":"Cox","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0530","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/dc19-0120","article-title":"The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the aric study","volume":"42","author":"Rawlings","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0535","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1210\/jc.2017-00439","article-title":"Alternative measures of hyperglycemia and risk of Alzheimer's disease in the community: the hisayama study","volume":"102","author":"Mukai","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/bs.acc.2021.07.006_bb0540","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging","volume":"70","author":"Thambisetty","year":"2013","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0545","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/07853890.2017.1290821","article-title":"Cardiovascular risk factors and glucose tolerance in midlife and risk of cognitive disorders in old age up to a 49-year follow-up of the Helsinki businessmen study","volume":"49","author":"Rantanen","year":"2017","journal-title":"Ann. Med."},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0550","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/bs.acc.2021.07.006_bb0555","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.3760\/cma.j.issn.0366-6999.20130162","article-title":"Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis","volume":"126","author":"Chen","year":"2013","journal-title":"Chin. Med. J."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0560","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/00207454.2016.1149172","article-title":"Functional genomics of candidate genes derived from genome-wide association studies for five common neurological diseases","volume":"127","author":"Guio-Vega","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0565","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/jnr.24133","article-title":"Association of CYP2R1 rs10766197 with MS risk and disease progression","volume":"96","author":"Scazzone","year":"2018","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002254","article-title":"APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts","volume":"14","author":"Qian","year":"2017","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/bs.acc.2021.07.006_bb0575","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0580","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3233\/JAD-180507","article-title":"Relationship between amyloid-\u03b2 positivity and progression to mild cognitive impairment or dementia over 8 years in cognitively normal older adults","volume":"65","author":"Dang","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0585","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.neurobiolaging.2013.06.002","article-title":"Substantial effects of apolipoprotein E \u025b4 on memory decline in very old age: longitudinal findings from a population-based sample","volume":"34","author":"Praetorius","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0590","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1533317515587084","article-title":"Glucose dysregulation interacts with APOE-\u220a4 to potentiate temporoparietal cortical thinning","volume":"31","author":"Foley","year":"2016","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"issue":"11","key":"10.1016\/bs.acc.2021.07.006_bb0595","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1212\/WNL.0000000000001379","article-title":"Effects of vascular risk factors and APOE \u025b4 on white matter integrity and cognitive decline","volume":"84","author":"Wang","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0600","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/joim.13071","article-title":"Joint impact of common risk factors on incident dementia: a cohort study of the Swedish Twin Registry","volume":"288","author":"Tomata","year":"2020","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0605","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0610","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc16-0843","article-title":"APOE genotypes associate with cognitive performance but not cerebral structure: diabetes heart study MIND","volume":"39","author":"Palmer Allred","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2021.07.006_bb0615","first-page":"702972","article-title":"Dementia and diabetes mellitus: association with apolipoprotein e4 polymorphism from a hospital in southern India","volume":"2012","author":"Kota","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0620","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00592-019-01322-9","article-title":"Dementia complicating type 2 diabetes and the influence of premature mortality: the Fremantle Diabetes Study","volume":"56","author":"Bruce","year":"2019","journal-title":"Acta Diabetol."},{"issue":"10","key":"10.1016\/bs.acc.2021.07.006_bb0625","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002853","article-title":"Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: a COSMIC collaboration cohort study","volume":"16","author":"Lipnicki","year":"2019","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0635","article-title":"Interaction between APOE genotype and diabetes in cognitive decline","volume":"12","author":"Shinohara","year":"2020","journal-title":"Alzheimers Dement. (Amst.)"},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0640","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1212\/WNL.0b013e318211c3ae","article-title":"Cerebrovascular risk factors and preclinical memory decline in healthy APOE \u025b4 homozygotes","volume":"76","author":"Caselli","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0645","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2174\/15672050113109990006","article-title":"Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE \u025b.4 carrier status","volume":"10","author":"Malek-Ahmadi","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0650","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3233\/JAD-160163","article-title":"Interaction between midlife blood glucose and APOE genotype predicts later Alzheimer's disease pathology","volume":"53","author":"Bangen","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.acc.2021.07.006_bb0655","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40035-019-0151-2","article-title":"Cognitive decline is related to high blood glucose levels in older Chinese adults with the ApoE \u025b3\/\u025b3 genotype","volume":"8","author":"Qiu","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0660","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3233\/JAD-191068","article-title":"Diabetes mellitus increases risk of incident dementia in APOE\u025b4 carriers: a meta-analysis","volume":"74","author":"Li","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/bs.acc.2021.07.006_bb0665","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/alz.12161","article-title":"Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status","volume":"16","author":"Wu","year":"2020","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0670","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-200232","article-title":"Pre-diabetes, but not type 2 diabetes, is related to brain amyloid in late middle-age","volume":"75","author":"Luchsinger","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0675","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-180297","article-title":"Metabolic syndrome and amyloid accumulation in the aging brain","volume":"65","author":"Gomez","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0680","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3233\/JAD-2011-111007","article-title":"CSF A\u03b2\u2081\u208b\u2084\u2082 levels and glucose metabolism in Alzheimer's disease","volume":"27","author":"Dumurgier","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0685","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-190620","article-title":"Classification of clinically diagnosed Alzheimer's disease associated with diabetes based on amyloid and tau PET results","volume":"71","author":"Takenoshita","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/bs.acc.2021.07.006_bb0690","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/ggi.13745","article-title":"Amyloid burden in diabetes-related dementia","volume":"19","author":"Takenoshita","year":"2019","journal-title":"Geriatr Gerontol Int"},{"issue":"7","key":"10.1016\/bs.acc.2021.07.006_bb0695","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1532-5415.2010.02854.x","article-title":"Glycemia and levels of cerebrospinal fluid amyloid and tau in patients attending a memory clinic","volume":"58","author":"Exalto","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0700","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2990.2008.00948.x","article-title":"Beta-amyloid deposition in brains of subjects with diabetes","volume":"35","author":"Alafuzoff","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0705","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-180914","article-title":"The clinical phenotype of vascular cognitive impairment in patients with type 2 diabetes mellitus","volume":"68","author":"Groeneveld","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"23","key":"10.1016\/bs.acc.2021.07.006_bb0710","doi-asserted-by":"crossref","first-page":"e3093","DOI":"10.1212\/WNL.0000000000010946","article-title":"Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline","volume":"95","author":"Pettigrew","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0715","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2337\/dc18-1399","article-title":"Importance of treatment status in links between type 2 diabetes and Alzheimer's disease","volume":"42","author":"McIntosh","year":"2019","journal-title":"Diabetes Care"},{"issue":"13","key":"10.1016\/bs.acc.2021.07.006_bb0720","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1212\/WNL.0000000000001982","article-title":"Type 2 diabetes mellitus and biomarkers of neurodegeneration","volume":"85","author":"Moran","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0725","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/WAD.0b013e31821764ce","article-title":"Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study","volume":"26","author":"Townsend","year":"2012","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0730","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-150575","article-title":"Association of plasma A\u03b240 peptides, but not A\u03b242, with coronary artery disease and diabetes mellitus","volume":"52","author":"Roeben","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0735","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/JAD-170534","article-title":"Subtle cognitive impairment and alzheimer's disease-type pathological changes in cerebrospinal fluid are common among neurologically healthy subjects","volume":"62","author":"Haapalinna","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0740","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer's disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0745","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2014-310095","article-title":"Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies","volume":"87","author":"Li","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/bs.acc.2021.07.006_bb0750","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2174\/1567205015666180709113338","article-title":"Amyloid and tau positron emission tomography in suggested diabetesrelated dementia","volume":"15","author":"Takenoshita","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0755","doi-asserted-by":"crossref","first-page":"9766","DOI":"10.1038\/s41598-017-09577-4","article-title":"Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults","volume":"7","author":"Laws","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0760","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3233\/JAD-160110","article-title":"Insulin resistance is associated with increased levels of cerebrospinal fluid biomarkers of Alzheimer's disease and reduced memory function in at-risk healthy middle-aged adults","volume":"52","author":"Hoscheidt","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0765","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-150072","article-title":"Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOE\u025b4 carriers","volume":"46","author":"Starks","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0770","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-170522","article-title":"Association of cerebrospinal fluid (CSF) insulin with cognitive performance and CSF biomarkers of Alzheimer's disease","volume":"61","author":"Geijselaers","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0775","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/WAD.0000000000000332","article-title":"Type 2 diabetes interacts with Alzheimer disease risk factors to predict functional decline","volume":"34","author":"Thomas","year":"2020","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0780","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12913-020-05360-w","article-title":"Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs","volume":"20","author":"Mata-Cases","year":"2020","journal-title":"BMC Health Serv. Res."},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0785","doi-asserted-by":"crossref","first-page":"310","DOI":"10.12968\/jowc.2018.27.5.310","article-title":"Perception of diabetic foot ulcers among general practitioners in four European countries: knowledge, skills and urgency","volume":"27","author":"Garcia-Klepzig","year":"2018","journal-title":"J. Wound Care"},{"issue":"5","key":"10.1016\/bs.acc.2021.07.006_bb0790","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2019.01.004","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum","volume":"15","author":"Bos","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/bs.acc.2021.07.006_bb0795","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/bs.acc.2021.07.006_bb0800","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer's disease biomarkers: a pilot clinical trial","volume":"57","author":"Craft","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0805","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2015-2315","article-title":"Cognitive effects of intentional weight loss in elderly obese individuals with mild cognitive impairment","volume":"101","author":"Horie","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2021.07.006_bb0810","first-page":"7","article-title":"Frequent follow-up visits reduce weight regain in long-term management after bariatric surgery","volume":"10","author":"Lombardo","year":"2015","journal-title":"Bariatr. Surg. Pract. Patient Care"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0815","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.numecd.2015.02.012","article-title":"Iron status in obesity: an independent association with metabolic parameters and effect of weight loss","volume":"25","author":"Guglielmi","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"16","key":"10.1016\/bs.acc.2021.07.006_bb0820","first-page":"7152","article-title":"Sarcopenic obesity: etiology and lifestyle therapy","volume":"23","author":"Lombardo","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0825","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-018-1055-2","article-title":"Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats","volume":"15","author":"Chunchai","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/bs.acc.2021.07.006_bb0830","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12974-020-01760-1","article-title":"Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice","volume":"17","author":"Shi","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/bs.acc.2021.07.006_bb0835","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2020.04.007","article-title":"Use of troponin as a predictor for cardiovascular diseases in patients with type 2 diabetes mellitus","volume":"507","author":"Bellia","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/bs.acc.2021.07.006_bb0840","doi-asserted-by":"crossref","first-page":"020901","DOI":"10.11613\/BM.2019.020901","article-title":"Establishing the 99(th) percentile for high sensitivity cardiac troponin I in healthy blood donors from Southern Italy","volume":"29","author":"Agnello","year":"2019","journal-title":"Biochem. Med. (Zagreb)"},{"issue":"6","key":"10.1016\/bs.acc.2021.07.006_bb0845","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2337\/dc19-2043","article-title":"Performance of high-sensitivity cardiac troponin assays to reflect comorbidity burden and improve mortality risk stratification in older adults with diabetes","volume":"43","author":"Tang","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242321000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242321000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T08:03:43Z","timestamp":1753344223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242321000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323988490"],"references-count":168,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2021.07.006","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}